| A-01 Registration at the conference venue Tuesday 14:00-18:00 |
| A-02 Welcome reception with drinks and light snacks (no dinner) Tuesday 18:00-19:30 |
| B-01 Registration at the conference venue Wednesday 08:00-08:45 |
| B-02 Welcome and introduction Wednesday 08:45-09:00 |
| B-03 Jeff Sachs Pharmacometrics: A shot in the arm for vaccine discovery and development ~or~ Vaccines are not immune to the charms of pharmacometrics Wednesday 09:00-09:45 |
| B-03 Keynote lecture Wednesday 09:00-09:45 |
| B-04 Siv Jonsson PAGE scientific program Wednesday 09:45-09:50 |
| B-05 Coffee break, poster and software session I: posters in Group I (with poster numbers starting with I-) are accompanied by their presenter Wednesday 09:50-11:15 |
| B-06 Marjorie Imperial Stratified medicine approaches for drug susceptible tuberculosis patients Wednesday 11:15-11:35 |
| B-06 Infectious diseases Wednesday 11:15-12:15 |
| B-07 Stefanie Hennig Repeated time-to-event models support that Pseudomonas aeruginosa infection increase the risk of acquiring Aspergillus in young children with cystic fibrosis Wednesday 11:35-11:55 |
| B-08 María García-Cremades Individual level data meta-analysis from HIV pre-exposure prophylaxis (PrEP) clinical trials Wednesday 11:55-12:15 |
| B-09 Lunch Wednesday 12:15-13:45 |
| B-10 Nicky Best Use of informative priors in model-informed drug development Wednesday 13:45-14:30 |
| B-10 Tutorial Wednesday 13:45-14:30 |
| B-11 Machine learning in oncology Wednesday 14:30-15:10 |
| B-11 Chiara Nicolò Machine learning combined to mechanistic modeling of differential effects of neoadjuvant sunitinib on primary tumor and metastatic growth Wednesday 14:30-14:50 |
| B-12 Sebastien Benzekry Machine learning versus mechanistic modeling for prediction of metastatic relapse in breast cancer Wednesday 14:50-15:10 |
| B-13 Coffee break, poster and software session I: posters in Group II (with poster numbers starting with II-) are accompanied by their presenter Wednesday 15:10-16:40 |
| B-14 Clinical pharmacometrics - ISoP special interest group Wednesday 16:40-16:45 |
| B15 Clinical applications Wednesday 16:45-17:25 |
| B-15 João Abrantes Bayesian forecasting utilizing bleeding information to support dose individualization of factor VIII Wednesday 16:45-17:05 |
| B-16 Belén Pérez Solans Model-based characterization of neutrophil dynamics in children receiving busulfan or treosulfan for hematopoietic stem cell transplant conditioning Wednesday 17:05-17:25 |
| B-17 Zinnia Parra-Guillen Disease pharmacokinetic-pharmacodynamic (PKPD) modelling to support the development of gene therapy treatments for rare diseases Wednesday 17:25-17:45 |
| B-17 Rare (and other) diseases Wednesday 17:25-18:05 |
| B-18 Pascal Chanu A disease progression model for geographic atrophy Wednesday 17:45-18:05 |
| C-01 Moustafa M. A. Ibrahim Competing risks analysis of the Finnish diabetes prevention study Thursday 08:30-08:55 |
| C-01 Lewis Sheiner Student Session Thursday 08:30-09:45 |
| C-02 Sebastiaan Goulooze Novel pharmacometric techniques to quantify and prevent iatrogenic withdrawal in children Thursday 08:55-09:20 |
| C-03 Elena Tosca Dynamic Energy Budget (DEB) based models of tumor-in-host growth inhibition and cachexia onset Thursday 09:20-09:45 |
| C-04 Presentation LBS awards Thursday 09:45-09:50 |
| C-05 Special announcement Thursday 09:50-09:55 |
| C-06 Coffee break, poster and software session I: posters in Group III (with poster numbers starting with III-) are accompanied by their presenter Thursday 09:55-11:20 |
| C-07 Kristin Karlsson Regulatory model-informed drug discovery and development in EU – News flash and examples Thursday 11:20-12:05 |
| C-07 Regulatory model-informed drug discovery and development Thursday 11:20-12:25 |
| C-08 Sylvie Retout A model-based extrapolation enabled labelling of emicizumab in haemophilia A paediatric patients <1 year old despite lack of clinical data Thursday 12:05-12:25 |
| C-09 ACoP Announcement Thursday 12:25-12:30 |
| C-10 Lunch Thursday 12:30-14:00 |
| C-11 ISoP Student Community meet-and-greet during lunch Thursday 12:30-14:00 |
| C-12 Stuart Beal methodology session Thursday 14:00-15:20 |
| C-12 Theodoros Papathanasiou Model based optimization of dose-finding studies for drug-combinations. Thursday 14:00-14:20 |
| C-13 Antonio Goncalves Model Averaging in viral dynamic models Thursday 14:20-14:40 |
| C-14 Mohammed Cherkaoui Rbati A liver model for chemoprotection against malaria Thursday 14:40-15:00 |
| C-15 Xiao Zhu A cohesive model framework of receptor pharmacology: beyond the Emax model Thursday 15:00-15:20 |
| C-16 WCoP Announcement Thursday 15:20-15:25 |
| C-17 Coffee break, poster and software session I: posters in Group IV (with poster numbers starting with IV-) are accompanied by their presenter Thursday 15:25-16:50 |
| C-18 Alison Margolskee Exploratory graphics (xGx): promoting the purposeful exploration of PKPD data Thursday 16:50-17:10 |
| C-18 Stuart Beal methodology session, continued Thursday 16:50-17:30 |
| C-19 Marc Cerou Performance of npde for the evaluation of joint model with time to event data Thursday 17:10-17:30 |
| C-20 Social event Thursday 18:30-01:00 |
| D-01 Aurelia de Vries Schultink Prospective evaluation of Therapeutic Drug Monitoring of endoxifen: feasibility of observational and randomized trials. Friday 09:20-09:40 |
| D-01 Oncology Friday 09:20-09:40 |
| D-02 Coralie Tardivon Association between tumor size kinetics and survival in advanced urothelial carcinoma patients treated with atezolizumab: implication for patient’s follow-up Friday 09:40-10:00 |
| D-03 Jiajie Yu A new approach to predict PFS in Ovarian Cancer based on tumor growth dynamics. Friday 10:00-10:20 |
| D-04 Preview of PAGE 2020 Friday 10:20-10:25 |
| D-05 Coffee break Friday 10:25-11:00 |
| D-06 Julie Janssen A semi-physiological framework to predict changes in pharmacokinetics of cytotoxic drugs in pregnant women Friday 11:00-11:20 |
| D-06 Oncology, continued Friday 11:00-11:40 |
| D-07 James Lu Integrated efficacy-safety QSP model of acute myeloid leukemia (AML) generates insights into the role of clinical dose schedules on cytopenia Friday 11:20-11:40 |
| D-08 Closing remarks Friday 11:40-11:50 |
| D-09 Audience input for potential PAGE 2020 topics Friday 11:50-12:05 |
